The link between erectile and cardiovascular health: The canary in the coal mine

American Journal of Cardiology

Volumn 108, Issue 4, 2011, Pages 599-606

  Meldrum, David R ^a   Gambone, Joseph C ^a   Morris, Marge A ^b   Meldrum, Donald A N ^c   Esposito, Katherine ^d   Ignarro, Louis J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ARGININE; ASCORBIC ACID; CALCIUM; CITRULLINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; GINSENG EXTRACT; INSULIN; IRBESARTAN; LOSARTAN; NITRIC OXIDE; OMEGA 3 FATTY ACID; PLACEBO; PYCNOGENOL; SILDENAFIL; TADALAFIL; TESTOSTERONE; VALSARTAN;

ABDOMINAL OBESITY; ACUTE HEART INFARCTION; ALCOHOL CONSUMPTION; BLEEDING; CANARY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; COAL MINING; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG MEGADOSE; ERECTILE DYSFUNCTION; EXERCISE; HUMAN; HYPERTENSION; IMMOBILIZATION; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MEDITERRANEAN DIET; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SEXUAL BEHAVIOR; WEIGHT CONTROL;

CARDIOVASCULAR DISEASES; ERECTILE DYSFUNCTION; HUMANS; LIFE STYLE; MALE; NITRIC OXIDE; PENILE ERECTION; RISK FACTORS;

EID: 79960930303     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.03.093     Document Type: Review

References (92)

1. Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992; 326:90-94.
2. Napoli C, Ignarro LJ. Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res 2009;32:1103-1108.
3. Fung MM, Bettencourt R, Barrett-Connor E. Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study. J Am Coll Cardiol 2004;43:1405-1411. (Pubitemid 38496346)
4. Shamloul R, Ghanem HM, Salem A, Elnashaar A, Elnaggar W, Darwish H, Mousa AA. Correlation between penile duplex findings and stress electrocardiography in men with erectile dysfunction. Int J Impot Res 2004;16:235-237. (Pubitemid 38858955)
5. Chiurlia E, D'Amico R, Ratti C, Granata AR, Romagnoli R, Modena MG. Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. J Am Coll Cardiol 2005;46:1503-1506. (Pubitemid 41446186)
6. Esposito K, Giugliano F, Martedi E, Feola G, Marfella R, D'Armiento M, Giugliano D. High proportions of erectile dysfunction in men with the metabolic syndrome. Diabetes Care 2005;28:1201-1203. (Pubitemid 40616635)
7. Eaton CB, Liu YL, Mittleman MA, Miner M, Glasser DB, Rimm EB. A retrospective study of the relationship of biomarkers of atherosclerosis and erectile dysfunction in 988 men. Int J Impot Res 2007;19:218-225. (Pubitemid 46340843)
8. Montorsi F, Briganti A, Salonia A, Rigatti P, Margonato A, Macchi A, Galli S, Ravagnani PM, Montorsi P. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 2003;44:360-364.
9. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61. (Pubitemid 24046934)
10. Inman BA, St. Sauver JL, Jacobson DL, Mcgree ME, Nehra A, Lieber MM, Roger VL, Jacobsen SJ. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 2009;84:108-113.
11. Buga GM, Gold ME, Fukuto JM, Ignarro LJ. Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 1991;17:187-193.
12. Cheng C, van Haperen R, de Waard M, van Damme LCA, Tempel D, Hanemaaijer L, van Cappellen GWA, Bos J, Slager CJ, Duncker DJ, van der Steen AFW, de Crom R, Krams R. Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique. Blood 2005;106:3691-3698. (Pubitemid 41739002)
13. Harrison DG, Widder J, Grumbach I, Chen W, Weber M, Searles C. Endothelial mechanotransduction, nitric oxide and vascular inflammation. J Intern Med 2006;259:351-363. (Pubitemid 43384226)
14. Hambrecht R, Adams V, Erbs S, Linke A, Krankel N, Shu Y, Baither Y, Gielen S, Thiele H, Gummert JF, Mohr FW, Schuler G. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 2003;107:3152-3158. (Pubitemid 36793084)
15. Haram PM, Adams V, Kemi OJ, Brubakk AO, Hambrecht R, Ellingsen O, Wisloff U. Time-course of endothelial adaptation following acute and regular exercise. Eur J Cardiovasc Prev Rehabil 2006;13: 585-591. (Pubitemid 44162161)
16. Yang AL, Su CT, Lin KL, Chao JI, You HP, Lee SD. Exercise training improves insulin-induced and insulin-like growth factor-1-induced vasorelaxation in rat aortas. Life Sci 2006;79:2017-2021.
17. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Int Med 2003;139: 161-168.
18. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med 2007;120:151-157. (Pubitemid 46175775)
19. Akkus E, Kadioglu A, Esen A, Doran S, Ergen A, Anafarta K, Hattat H; Turkish Erectile Dysfunction Prevalence Study Group. Prevalence and correlates of erectile dysfunction in Turkey: a population-based study. Eur Urol 2002;41:298-304. (Pubitemid 35303429)
20. Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000;56:302-306. (Pubitemid 30495587)
21. Giugliano F, Maiorino M, Bellastella G, Gicchino M, Giugliano D, Esposito K. Determinants of erectile dysfunction in type 2 diabetes. Int J Impot Res 2010;22:204-209.
22. Ma R C-W, So W-Y, Yang Z, Yu LW, Kong AP, Ko GT, Chow CC, Cockram CS, Chan JC, Tong PC. Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J Am Coll Cardiol 2008;51: 2045-2050. (Pubitemid 351680526)
23. Gazzaruso C, Solerte SB, Pujia A, Coppola A, Vezzoli M, Salvucci F, Valenti, C, Giustina A, Garzaniti A. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease. A potential role for statins and 5-phosphodiesterase inhibitors. J Am Coll Cardiol 2008;51:2040-2044. (Pubitemid 351689055)
24. Giugliano F, Esposito K, Di Palo C, Ciotola M, Giugliano G, Marfella R, D'Armiento M, Giugliano D. Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokines in obese men. J Endocrinol Invest 2004;27:665-669. (Pubitemid 39359830)
25. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F, D'Armiento M, Giugliano D. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled study. JAMA 2004;291:2978-2984. (Pubitemid 38802687)
26. Roberts CK, Nosratola D, Vaziri MD, Barnard J. Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation 2002;106:2530-2532. (Pubitemid 35340686)
27. Doumas M, Tsakiris A, Douma S, Grigorakis A, Papadopoulos A, Hounta A, Tsiodras S, Dimitriou D, Giamarellou H. Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared with normotensive subjects. J Androl 2006;27:469-477. (Pubitemid 43667997)
28. Bohm M, Baumhakel M, Teo K, Sleight P, Probstfield J, Gao P. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease (ONTARGET/TRANSCEND) trials. Circulation 2010;121:1439-1446.
29. Fogari R, Zoppi A, Poletti L, Marasi G, Mugellini A, Corradi L. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens 2001; 14:27-31. (Pubitemid 32105914)
30. Baumhakel M, Schlimmer N, Bohm M; DO-IT Investigators. Effect of Irbesartan on erectile function in patients with hypertension and metabolic syndrome. Int J Impot Res 2008;20:493-500.
31. Flammer AJ, Hermann F, Wiesli P, Schwegler B, Chenevard R, Hurlimann D, Sudano I, Gay S, Neidhart M, Riesen W, Ruschitzka F, Luscher TF, Noll G, Lehmann R, Lehmann R. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension. J Hypertens 2007;25:785-791. (Pubitemid 46398873)
32. Kris-Etherton PM, Harris WS, Appel LJ; American Heart Association Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747-2757. (Pubitemid 35364932)
33. Okuda Y, Kawashima K, Sawada T, Tsurumaru K, Asano M, Suzuki S, Soma M, Nakajima T, Yamashita K. Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem Biophys Res Commun 1997;232:487-491. (Pubitemid 27216245)
34. Tagliabue M, Pinach S, Di Bisceglie C, Brocato L, Cassader M, Bertagna A, Manieri C, Pescarmona GP. Glutathione levels in patients with erectile dysfunction, with or without diabetes mellitus. Int J Androl 2005;28:156-162. (Pubitemid 40780342)
35. Ignarro LJ, Byrns RE, Sumi D, de Nigris F, Napoli C. Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biologic actions of nitric oxide. Nitric Oxide 2006;15:93-102. (Pubitemid 44175887)
36. Fisher ND, Hughes M, Gerhard-Herman M, Hollenberg NK. Flavanolrich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens 2003;21:2281-2286. (Pubitemid 38293567)
37. Kalea AZ, Clark K, Schuschke DA, Klimis-Zacas DJ. Vascular reactivity is affected by dietary consumption of wild blueberries in the Sprague-Dawley rat. J Med Food 2009;12:21-28.
38. Persson IA, Josefsson M, Persson K, Andersson RG. Tea flavanols inhibit angiotensin-converting enzyme activity and increase nitric oxide production in human endothelial cells. J Pharm Pharmacol 2006; 58:1139-1144. (Pubitemid 44213648)
39. Wallerath T, Poleo D, Li H, Forstermann U. Red wine increases the expression of human endothelial nitric oxide synthase: a mechanism that may contribute to its beneficial cardiovascular effects. J Am Coll Cardiol 2003;41:471-478. (Pubitemid 36164505)
40. Janszky I, Mukamal KJ, Ljung R, Ahnve S, Ahlbom A, Hallkvist J. Chocolate consumption and mortality following a first acute myocardial infarction: the Stockholm Heart Epidemiology Program. J Intern Med 2009;266:248-257.
41. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Tea consumption and mortality after acute myocardial infarction. Circulation 2002;105:2476-2481. (Pubitemid 34568967)
42. Faridi Z, Njike VY, Dutta S, Ali A, Katz DL. Acute dark chocolate and cocoa ingestion and endothelial function: a randomized controlled crossover trial. Am J Clin Nutr 2008;88:58-63. (Pubitemid 351988683)
43. Meldrum DR, Gambone JC, Morris MA, Ignarro LJ. A multifaceted approach to maximize erectile function and vascular health. Fertil Steril 2010;94:2514-2520.
44. Moens AL, Vrints CJ, Claeys MJ, Timmermans JP, Kass DA. Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease. Am J Physiol Heart Circ Physiol 2008;249:H1971-1977.
45. Mathers JC. Folate intake and bowel cancer risk. Genes Nutr 2009;4: 173-178.
46. Lopez-Jaramillo P, Gonzalez MC, Palmer RMJ, Moncada S. The crucial role of physiologic Ca2+ concentrations in the production of endothelial nitric oxide and the control of vascular tone. Br J Pharmacol 1990;101:489-493. (Pubitemid 20292911)
47. van Mierlo LAJ, Arends LR, Streppel MT, Zeegers MPA, Kok FJ, Grobbee DE, Geleijnse JM. Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J Hum Hypertens 2006;20:571-580. (Pubitemid 44088959)
48. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk factors for prostatic cancer incidence and progression in the health professionals follow-up study. Int J Cancer 2007;121:1571-1578. (Pubitemid 47328718)
49. Bolland MJ, Avenell A, Baron JA, Grey A, Maclennan GS, Gamble GD. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010;341:c3691.
50. Tomasian D, Keaney JF, Vita JA. Antioxidants and the bioactivity of endothelium-derived nitric oxide. Cardiovasc Res 2000;47:426-435. (Pubitemid 30646065)
51. Hamilton IM, Gilmore WS, Benzie IF, Mulholland CW, Strain JJ. Interactions between vitamins C and E in human subjects. Br J Nutr 2000;84:261-267.
52. Miller ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dose vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005;142:37-46.
53. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, Gaziano JM. Vitamins C and E in the prevention of cardiovascular disease in men: the Physicians Health Study II randomized controlled trial. JAMA 2008;300:2123-2133.
54. González-Correa JA, Arrebola MM, Guerrero A, Muñoz- Marín J, Ruiz-Villafranca D, Sánchez de La Cuesta F, De La Cruz JP. Influence of vitamin E on the antiplatelet effect of acetylsalicylic acid in human blood. Platelets 2005;16:171-179. (Pubitemid 40910905)
55. Radomski MW, Palmer RMJ, Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacycline and nitric oxide. Br J Pharmacol 1987;92:639-646.
56. Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, Collins R, Emberson J, Goswin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. Lancet 2009;373:1849-1860.
57. Palmer RMJ, Ferrige AG, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-666.
58. Hecker M, Sessa WC, Harris J, Anggard EE, Vane JR. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: Cultured endothelial cells recycle Lcitrulline to L-arginine. Proc Natl Acad Sci U S A 1990;87:8612-8616.
59. Hayashi T, Juliet PA, Matsui-Hirai H, Miyazaki A, Fukatsu A, Funami J, Iguchi A, Ignarro LJ. L-Citrulline and L-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits. Proc Natl Acad Sci U S A 2005;102:13681-13686. (Pubitemid 41420908)
60. Klotz T, Mathers MJ, Braun M, Bloch W, Engelmann U. Effectiveness of oral L-arginine in first-line treatment of erectile dysfunction in a controlled crossover study. Urol Int 1999;63:220-223. (Pubitemid 30072009)
61. Chen J, Wollman Y, Chernichovsky T, Iaina A, Sofer M, Matzkin H. Effect of oral administration of high-dose nitric oxide donor L-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled study. BJU Int 1999;83:269-273. (Pubitemid 29151525)
62. Zorgniotti AW, Lizza EF. Effect of large doses of the nitric oxide precursor, L-arginine, on erectile dysfunction. Int J Impot Res 1994; 6:33-35.
63. Schwedhelm E, Maas R, Freese R, Jung D, Lukacs Z, Jambrecina A, Spickler W, Schultz F, Boger RH. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol 2008;65:51-59. (Pubitemid 350265175)
64. Moncada S, Higgs EA. Nitric oxide and the vascular endothelium. Handb Exp Pharmacol 2006;176:213-254.
65. Schulman SP, Becker LC, Kass DA, Champion, HC, Terrin ML, Forman S, Ernst KV, Kelemen MD, Townsend SN, Caprioti A, Hare JM, Gerstenblith G. L-Arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA 2006;295:58-64. (Pubitemid 43042690)
66. Stanworth RD, Jones TH. Testosterone for the aging male: current evidence and recommended practice. Clin Interv Aging 2008;3:25-44. (Pubitemid 351559801)
67. Akishita M, Hashimoto M, Ohike Y, Ogawa S, Iijima K, Eto M, Ouchi Y. Low testosterone level is an independent determinant of endothelial dysfunction in men. Hypertens Res 2007;30:1029-1034.
68. Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB, McKinlay JB. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 2000;30:328-338. (Pubitemid 30211093)
69. Peluffo G, Calcerrada P, Piacenza L, Pizzano N, Radi F. Superoxide-mediated inactivation of nitric oxide and peroxinitrite formation by tobacco smoke in vascular endothelium: studies in cultured cells and smokers. Am J Physiol Heart Circ Physiol 2009;96:H1781-H1792.
70. Cheng JYW, Ng EML, Chen RL, Ko JSN. Alcohol consumption and erectile dysfunction: meta-analysis of population-based studies. Int J Impot Res 2007;19:343-352. (Pubitemid 47026091)
71. Abou-agag LH, Khoo NK, Binsack R, White CR, Darley-Usmar V, Grenett HE, Booyse FM, Digerness SB, Zhou F, Parks DA. Evidence of cardiovascular protection by moderate alcohol: role of nitric oxide. Free Radic Biol Med 2005;39:540-548. (Pubitemid 41021652)
72. Aydinoglu F, Yilmaz SN, Coskun B, Daglioglu N. Ogulener N. Effects of ethanol treatment on the neurogenic and endothelium-dependent relaxation of corpus cavernosum smooth muscle in the mouse. Pharmacol Rep 2008;60:725-734.
73. Koskimaki J, Shiri R, Tammela T, Hakkinen J, Hakama M, Auvinen A. Regular intercourse protects against erectile dysfunction: Tampere Aging Male Urologic Study. Am J Med 2008;121:592-596.
74. Murad F. Shattuck Lecture: nitric oxide and cyclic GMP in cell signaling and drug development. N Engl J Med 2006;395:2003-2011. (Pubitemid 44708019)
75. Verit A, Savas M, Ciftci H, Aksoy N, Taskin A, Topal U. Assessment of the acute effects of tadalafil on the cardiovascular system based on examination of serum oxidative status and paraoxonase activity in men with erectile dysfunction: a preliminary study. Int J Impot Res 2010; 22:115-119.
76. Ciftci H, Yeni E, Savas M, Verit A, Celik H. Paraoxinase activity in patients with erectile dysfunction. Int J Impot Res 2007;19:517-520. (Pubitemid 47367529)
77. Soran H, Jounis NN, Charlton-Menys V, Durrington P. Variation in paraoxonase-1 activity and atherosclerosis. Curr Opin Lipidol 2009; 20:265-274.
78. Rosano GMC, Aversa A, Vitale C, Fabbri A, Fini M, Spera G. Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur Urol 2005;47:214-222. (Pubitemid 40126979)
79. Boulanger C, Luscher TF. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 1990;85:587-590. (Pubitemid 20070070)
80. Schafer A, Fraccarollo D, Pfortsch S, Flierl U, Vogt C, Pfrang J, Kobsar A, Renné A, Eigenthaler M, Ertl G, Bauersachs J. Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus. Br J Pharmacol 2008;153:886-893. (Pubitemid 351328925)
81. Oliver JJ, Melville VP, Webb DJ. Effect of regular phosphodiesterase type 5 inhibition in hypertension. Hypertension 2006;48:622-627. (Pubitemid 44843865)
82. Kostis JB, Jackson G, Rosen R, Barrett-Connor E, Billups K, Burnett AL, Carson C III. Second Princeton Consensus Conference. Am J Cardiol 2005;96(suppl):85M-93M.
83. Fagard RH, Cornelissen VA. Effect of exercise on blood pressure control in hypertensive patients. Eur J Cardiovasc Prev Rehabil 2007; 14:12-17.
84. Forman JP, Stampfer MJ, Curhan GC. Diet and lifestyle factors associated with incident hypertension in women. JAMA 2009;302:401-411.
85. Foster GD, Wyatt HR, Hill JO, Makris AP, Rosenbaum DL, Brill C, Stein RI, Mohammed BS, Miller B, Rader DJ, Zemel B, Wadden TA, Tenhave T, Newcomb CW, Klein S. Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low fat diet: a randomized trial. Ann Intern Med 2010;153:147-157.
86. Esposito K, Ciotola M, Giugliano F, De Sio M, Giugliano G, D'armiento M, Giugliano D. Mediterranean diet improves erectile function in subjects with the metabolic syndrome. Int J Impot Res 2006;18:405-410.
87. Richard C, Couture P, Desroches S, Charest A, Lamarche B. Effect of the Mediterranean diet with and without weight loss on cardiovascular risk factors in men with the metabolic syndrome. Nutr Metab Cardiovasc Dis. In press.
88. Bonaa KH, Bjerve KS, Straume B, Gram IT, Thelle D. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. N Engl J Med 1990;322:795-801.
89. Block G, Mangels AR, Norkus BP, Patterson BH, Levander OA, Taylor PR. Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension 2001;37:261-267. (Pubitemid 32199085)
90. Buijsse B, Feskens EJM, Kok FJ, Kromhout D. Cocoa intake, blood pressure, and cardiac mortality. The Zutphen Elderly Study. Arch Intern Med 2006;166:411-417.
91. Duffy SJ, Gokce N, Holbrook M, Huang A, Frei B, Keaney JF, Vita JA. Treatment of hypertension with ascorbic acid. Lancet 1999;354: 2048-2049.
92. Giugliano D, Giugliano F, Esposito K. Sexual dysfunction and the Mediterranean diet. Public Health Nutr 2006;9:1118-1120.